Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.89 Million USD | 77.25% |
| 2022 | -66.1 Million USD | -44.86% |
| 2021 | -45.63 Million USD | -10.18% |
| 2020 | -41.41 Million USD | 13.95% |
| 2019 | -48.13 Million USD | -753.85% |
| 2018 | 7.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -3.59 Million USD | 11.91% |
| 2023 Q1 | -4.08 Million USD | 85.84% |
| 2023 Q3 | -5.13 Million USD | -42.92% |
| 2023 Q4 | -2.22 Million USD | 56.73% |
| 2023 FY | -15.03 Million USD | 77.25% |
| 2022 Q4 | -28.81 Million USD | -42.92% |
| 2022 Q3 | -20.16 Million USD | -1827.63% |
| 2022 FY | -66.1 Million USD | -44.86% |
| 2022 Q2 | -1.04 Million USD | 95.7% |
| 2022 Q1 | -24.33 Million USD | -1.38% |
| 2021 FY | -45.63 Million USD | -10.18% |
| 2021 Q4 | -24 Million USD | -2512.06% |
| 2021 Q3 | 995 Thousand USD | 111.11% |
| 2021 Q2 | -8.95 Million USD | 34.94% |
| 2021 Q1 | -13.76 Million USD | -18.42% |
| 2020 Q4 | -11.62 Million USD | -128.19% |
| 2020 Q3 | -5.09 Million USD | 36.4% |
| 2020 Q2 | -8 Million USD | 13.71% |
| 2020 Q1 | -9.28 Million USD | 43.08% |
| 2020 FY | -41.41 Million USD | 13.95% |
| 2019 Q1 | -6.08 Million USD | 0.0% |
| 2019 FY | -48.13 Million USD | -753.85% |
| 2019 Q3 | -10.64 Million USD | -63.77% |
| 2019 Q4 | -16.3 Million USD | -53.25% |
| 2019 Q2 | -6.49 Million USD | -6.74% |
| 2018 FY | 7.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bright Green Corporation | -13.12 Million USD | -36.346% |
| BioQuest Corp. | -123.33 USD | -14512994.949% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 150.219% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 11426.115% |
| GSRX Industries Inc. | - USD | Infinity% |
| High Sierra Technologies, Inc. | -323.95 Thousand USD | -5425.201% |
| Instadose Pharma Corp. | - USD | Infinity% |